Joseph F. Boland

AstraZeneca (Singapore) — Singapore

Medicine · Health Sciences

32h-index3.4kcitations104works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cervical Cancer and HPV Research(32), RNA modifications and cancer(27), Molecular Biology Techniques and Applications(18), Sarcoma Diagnosis and Treatment(12), Cancer Genomics and Diagnostics(12)

Publications103 total

470 Multimodal profiling reveals unique and overlapping features of rilvegostomig and PD(x) activity in NSCLC tumor explants
Regular and Young Investigator Award Abstracts·2025Open Access
Cell lysis plus depletion single-nucleus RNA-seq (CL-D snRNAseq) v1
2025Open Access
Comprehensive cellular analysis with single-nucleus RNA-seq of archived PAXgene whole blood samples
2025Open Access
Somatic mutations in 3929 HPV positive cervical cells associated with infection outcome and HPV type
Nature Communications·2024· 7 citedOpen Access
Supplementary Table 5 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 3 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 6 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 4 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 2 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Data from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Figures 1 - 11 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 1 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 5 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 1 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 4 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 3 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 2 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 6 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Figures 1 - 11 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Data from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Meredith Yeager(38), Sara Bass(21), Michael Cullen(19), Mark Schiffman(16), Laurie Burdett(14), Stephen J. Chanock(14), Nicolas Wentzensen(13), Lisa Mirabello(12), David A. Roberson(11), Allan Hildesheim(11), Mia Steinberg(10), Kari G. Rabe(10), Aimée R. Kreimer(9), Carolina Porras(9), Sharon A. Savage(9), Xijun Zhang(9), Michael Dean(8), Jason Mitchell(8), Thomas Lorey(8), Robert D. Burk(8)